CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash flows from operating activities
Net earnings	$ 10,738	$ 10,962
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation	1,069	1,108
Amortization	219	343
Deferred taxes	(4,188)	(221)
Premium amortization, net of discount accretion	1,399	1,056
Gain on sale of loans	(905)	(1,398)
Reversal of provision for credit losses	(1,250)	(0)
Origination of loans held for sale	(25,758)	(32,850)
Proceeds from loans held for sale	29,626	35,127
Write-down of other real estate and repossessed assets	0	2
Net gain on sale of premises, equipment, other real estate owned and other assets	(39)	(50)
Stock based compensation	156	162
Net change in accrued interest receivable and other assets	6,792	(7,406)
Net change in accrued interest payable and other liabilities	804	3,049
Net cash provided by operating activities	18,663	9,884
Securities available for sale:
Purchases	0	(50,604)
Proceeds from maturities and principal repayments	14,431	19,776
Securities held to maturity:
Purchases	(915,587)	0
Proceeds from maturities and principal repayments	603,937	0
Net originations of loans	(106,123)	(45,685)
Purchases of premises and equipment	(1,685)	(799)
Proceeds from BOLI death benefit	0	464
Proceeds from sale of premises, equipment, other real estate owned and other assets	72	115
Net cash used in investing activities	(404,955)	(76,733)
Cash flows from financing activities
Net change in deposits	126,920	188,820
Net change in securities sold under agreements to repurchase	(3,061)	8,376
Proceeds from FHLB advances	0	40,000
Repayment of FHLB advances	(40,000)	(100,005)
Proceeds from line of credit	1,000	3,000
Repayment of line of credit	(6,000)	0
Proceeds from issuance of debentures	34,336	0
Purchase of treasury stock	(1,993)	0
Exercise of stock options	0	527
Cash dividends paid	(2,424)	(2,188)
Net cash provided by financing activities	108,778	138,530
Net change in cash and cash equivalents	(277,514)	71,681
Cash and cash equivalents at beginning of period	499,605	351,791
Cash and cash equivalents at end of period	222,091	423,472
Supplemental disclosures of cash flow information
Interest paid	1,460	2,067
Supplemental schedule of noncash investing and financing activities
Cash dividends accrued	2,656	2,411
Lease right of use assets obtained in exchange for lease liabilities		1,384
Transfer of loans to other real estate owned and repossessed assets	0	437
Contributions from noncontrolling interest	598	0
Stock dividend	$ 0	$ 35,947